It is clear that down-regulation of a specific component of lipid metabolism not only alters seed storage lipid content, but also affects other components of that pathway. The effects go even further in potentially altering the allocation of resources within the seed and lowering the proportion of seeds reaching maturity. It is clear that there must be some cross-talk between signalling pathways within the cell ; these pleiotropic effects obviously have great biological significance, as they give a clear indication that cellular events are connected. Future proteome and transcriptome analyses should help to elucidate the potential connections between these different components of metabolism and link metabolism to cell biology. These plants will form a useful resource for future metabolic flux analysis studies that are in progress. Regulation of Fatty Acid Synthesis 
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Acetyl-CoA carboxylase (ACC) isoform structure and function ACC catalyses the carboxylation of acetyl-CoA to malonyl-CoA, a major precursor for fatty acid synthesis [l] , but it is also a crucial regulator of mitochondria1 fatty acid /3-oxidation through its inhibition of carnitine palmitoyltransferase-1 (CPT1) [2] . The regulation of ACC, through a complex interaction of short-and long-term mechanisms, plays a key role in the control of both the synthesis and the oxidation of fatty acids.
In mammals, ACC is a multifunctional enzyme with biotin carboxyl carrier protein, biotin carboxylase and carboxyl transferase domains all contained within a single polypeptide chain [l] . A large body of evidence, including purification [3-61, immunological analysis 171 and cDNA cloning [8-111, has revealed two major isoforms of ACC with molecular masses of approx. 265 kDa (ACCl or ACCa) and 280 kDa (ACC2 or ACCB). The two isoforms are distinct gene products with the ACCa gene localized to human chromosome 17 [9] and the ACCj? gene localized to human chromosome 12 [lo] . The major difference between the isoforms is the extended N-terminus of ACCB. Outside this region, the isoforms exhibit considerable identity and have the same domain structure responsible for catalytic activity [lo] . Despite the identity, slight differences in the kinetic parameters of the two isoforms have been reported, with ACCP exhibiting lower K, values for ATP and HCO; and a higher K , value for acetyl-CoA [6, 7] . Both isoforms are activated by citrate with different K , values [6, 7] .
The distinct tissue distribution of the isoforms may be a better indicator of possible functional differences. In lipogenic tissues, such as white adipose tissue and lactating mammary gland, ACCa is the major form of ACC expressed. In oxidative tissues, such as heart and skeletal muscle, ACCP predominates. In liver, where both fatty acid synthesis and oxidation are important, there is significant expression of both isoforms [6,7,lO] .*Thus ACCP may be involved in the control of fatty acid oxidation, while ACCa controls fatty acid synthesis. There has been much speculation as to whether or not the unique N-terminal peptide of ACCB could function to anchor ACCB to the mitochondrial membrane, where it could produce malonyl-CoA in close proximity to the active site of CPT-1. There have been previous reports of mitochondria-associated forms of ACC [12] , but these have not always found support [ 13,141. Overexpression of the N-terminal peptide of ACCP [15] and expression of an antisense gene to the ACCP N-terminus [16] in H9c2 cardiomyocytes have suggested a specific (if undefined) role in fatty acid oxidation, but not fatty acid synthesis. The clearest evidence so far comes from Wakil and colleagues, who used immunofluorescent microscopic analysis with anti-ACCP antibodies, and green fluorescent protein fused to the C-terminus of the ACCB N-terminal domain, to show a mitochondrial location of ACCP [17] . Furthermore, they have reported significantly lowered levels of malonyl-CoA and elevated rates of fatty acid oxidation in heart and muscle of ACCP knockout mice [ 181.
The minimum molecular mass of native ACC suggests that the smallest form that occurs in vim is a dimer. Immunoprecipitation of ACC with specific ACCa or ACCB antibodies suggests that this could be a homodimer or a heterodimer of the two different isoforms [7, 19] . This dimer is frequently referred to as the protomeric form (12-13 S) which, in the presence of high concentrations of citrate, forms polymers (> 40 S) of up to 30 protomers in a linear array [3] . There is some evidence that the polymerization of the enzyme may be an integral part of its regulation.
Short-term regulation of ACC
Significant changes in the concentration of ACC do not occur rapidly, since the half-life of this enzyme varies from 1 to 3 days under different physiological conditions [20] . However, there is nutritional and hormonal control of ACC gene expression, as reviewed elsewhere [21] . The shortterm control of ACC activity is achieved via allosteric regulation and reversible phosphorylation and inactivation. These mechanisms appear to work for both isoforms, but with some subtle differences.
Allosteric regulation by citrate and fatty acyl-CoA
Citrate is a feedforward activator of ACC with a K, of approx. 2 mM [22] , so that the physiological range of cellular citrate concentrations (0.1-1 mM) is a potential allosteric activator in vivo. However, cell citrate concentrations do not always change in parallel with the activity of ACC [23, 24] . This is probably due to the potential overriding influence of phosphorylation. Citrate causes polymerization of ACC (see above), although it appears that the activation by citrate precedes polymerization [25] . However, there is evidence for protomer into polymer transitions in vivo, where the effects of insulin treatment on adipocyte ACC, and of insulin injection or refeeding starved rats on hepatic ACC, include the transition of ACC to a high-molecular-mass polymeric form, as judged by size exclusion chromatography [26, 27] . Insulin and glucose inhibit fatty acid oxidation in rat and human skeletal muscle via an increase in malonyl-CoA concentration, without a stable, measurable change in ACC activity [28, 29] . There is, however, a strong positive correlation between malonyl-CoA and increased concentrations of cell citrate and malate (that would promote citrate efflux from the mitochondria). This has led Ruderman and colleagues to propose that allosteric activation of ACCB by citrate rather than a change in its phosphorylation state is responsible for the increased malonyl-CoA levels [28, 29] . In acini isolated from lactating rat mammary gland we have observed a 11 5 f 21 % (n = 4) increase in ACC activity, accompanying a 3-fold increase in cell citrate concentration, following treatment with acetoacetate. 32P-labelling of cells revealed that ACC from treated cells was less phosphorylated than that from control cells. Phosphorylation and allosteric activation are clearly interactive mechanisms. Phosphorylation of pure ACC by CAMP-dependent protein kinase (PKA) or AMPactivated protein kinase (AMPK) both result in decreased sensitivity of ACC to citrate [22] . Conversely, a highly polymerized and citrateindependent form of rat liver ACC has been identified as being relatively dephosphorylated [27] . We have seen that citrate has a small inhibitory effect (25 f 1.9 yo, n = 4) on the rate of phosphorylation by AMPK of the SAMS peptide (a synthetic 15 amino acid peptide containing the sequence around Ser7' on ACC). However, citrate caused 77 3.4 % (n = 4) inhibition of the rate of phosphorylation of native ACC by AMPK. We conclude that the polymerization of ACC in the presence of citrate protects it from phosphorylation and that this could be the basis of the effect of raised citrate concentrations on ACC in acini in response to acetoacetate.
Long-chain fatty acyl-CoA esters are potent feedback inhibitors of ACC, at concentrations below the critical micelle concentration 
Phosphorylation and inactivation of ACC in vitro
The phosphorylation of ACCa in vitro has been well documented and, while a number of protein kinases are capable of this, only PKA and AMPK produce significant inactivation of the enzyme [22] . In rat ACCa, AMPK phosphorylates serine residues 79, 1200 and 1215, while PKA phosphorylates serine residues 77 and 1200. Phosphorylation of ACCa by either kinase produces an approx. 100 % increase in the K,, value for citrate Hardie and co-workers have shown that removal of the N-terminus of ACCa phosphorylated by either kinase results in full re-activation of the enzyme and have taken this to indicate that only serine residues 77 and 79 have any inhibitory effect on ACC [33] . The observation that Ser'7 contained no phosphate in vivo suggested that AMPK is the only kinase that could physiologically inactivate ACCa. However, Kim and co-workers expressed ACCa in HeLa cells and, although the enzyme possessed very low activity, mutation of Ser" abolished the inhibitory effects of AMPK phosphorylation and prevented Ser"" phosphorylation, but only the mutation of Ser"", and not Ser77, abolished the inhibitory effects of PKA [34] . Thus, the relative importance of phosphorylation of serine residues 79 and 1200 to the regulation of ACC activity, and whether PKA could play an inhibitory role in vivo, remains an open question.
ACCP is a phosphoprotein [4,5] and its regulation by reversible phosphorylation is crucial to its proposed role in the control of fatty acid oxidation. ACCP from rat liver or heart is a better substrate for PKA than ACCa [5,19], which is surprising, given that ACCP lacks an equivalent to the major PKA phosphorylation site at Ser'*'' in rat ACCa [ll] . This may be explained by the existence of four or five consensus sequences for PKA phosphorylation sites in the N-terminal extension of ACCP [ll]. There are conflicting reports that PKA phosphorylation of ACCP in vitro produces significant inactivation [ 191 or has no effect on activity [35, 36] . It is possible that phosphorylation of the N-terminal sites controls the association of ACCS with the mitochondria1 membrane and thus regulates C P T l and fatty acid oxidation through a targeting mechanism. ACCP and ACCa in rat liver appear to be equally good substrates for AMPK in vitro and phosphorylation of ACCP by AMPK causes inactivation [19, 36] in the form of an increased K, for citrate and decreased V,, [36] . SerZ1' in ACCP appears to be the equivalent of Ser7', the major phosphorylation site of AMPK, in ACCa [ll].
It is noteworthy that tryptic peptide maps of ACCP, phosphorylated by PKA and AMPK, show significant differences [35] .
Physiological phosphorylation and inactivation of ACC in vivo
The phosphorylation state of ACC in rat liver changes with nutritional and hormonal status. There is a diurnal rhythm [37] ; ACC is also phosphorylated and inactivated in response to prolonged food withdrawal [27, 38] , feeding rats a high-fat diet [37] , glucagon treatment of isolated hepatocytes [39] or glucagon administration to whole rats [40] . These physiological phosphorylations and inactivations of ACC are characterized by a large significant increase in the K , for citrate and an equally large decrease in the V,,, of the enzyme. Such changes in ACC V,,, values can only be explained by the effects of phosphorylation by AMPK, and not PKA. In support of the fact that AMPK is the physiological ACC kinase, it is Ser7g that becomes phosphorylated in rat liver ACC in response to in vzvo manipulations [37] and in hepatocytes in response to glucagon [39] .
Purification, cloning and expression of rat liver AMPK has revealed that it is heterotrimeric and consists of catalytic a and regulatory P and y subunits [41, 42] . Multiple isoforms of each subunit have been identified (a1 and a2 ; Pl and P2 ; y l , y2 and y3) and individual roles for these are under investigation. Witters and colleagues have reported that the a1 isoform specifically phosphorylates rat liver ACCa and ACCP [43] , yet Lopaschuk and colleagues report that the a2 isoform co-precipitates with immune complexes of ACCP from rat heart [19] . The major role of AMPK in the cell is to monitor its energy status and regulate the ATP-consuming and ATPproducing pathways accordingly. Thus when ATP is depleted and AMP concentrations rise, AMPK is activated by a multi-faceted mechanism comprising : (i) direct allosteric activation of AMPK by AMP; (ii) phosphorylation and activation by an upstream AMPK-kinase in a reaction that is stimulated by AMP; (iii) AMP inhibition of the dephosphorylation and inactivation of AMPK [41, 42, 44] . As ACCa catalyses the energyutilizing pathway of fatty acid synthesis in liver, it is a prime target for AMPK in times of oxidative stress. Thus, phosphorylation and inactivation of ACC have been demonstrated in liver, in response to anoxia [37] , in hepatocytes, in response to raising AMP through incubation with ATP depletors [44] , and in response to 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), a cell-soluble precursor to ZMP (AICAR monophosphate) that is an analogue of AMP [45] .
The mechanism of hormonally or nutritionally mediated phosphorylation of ACC by AMPK is unclear. Glucagon treatment of hepatocytes [39] or adrenaline treatment of adipocytes [46] results in the phosphorylation of Ser7g on ACCa by AMPK. Pharmacological blockade of cAMP action in adipocytes prevented this AMPKmediated phosphorylation of ACCa [46] , yet PKA is not the upstream AMPK kinase that activates AMPK. One can only speculate that the effects of cAMP are mediated through changes in the activity of ACC phosphatase, or some mechanism that targets AMPK to ACC (or vice versa). Where changes in AMPK activity in response to hormones have been reported, these have been linked to inverse changes in insulin concentration [38] and a direct inhibition of AMPK activity in Fao Reuber hepatoma cells, in response to insulin, has been observed [47] . Most recently, leptin has been shown to activate AMPK in skeletal muscle, resulting in phosphorylation and inactivation of ACCP and stimulation of fatty acid oxidation [48] . There is increasing evidence that AMPK can be activated in the cell in the absence of changes in the ATP:AMP ratio and it seems likely that a number of cell signalling pathways may converge upon the AMPK signalling cascade.
In times of low energy status, the role of AMPK is not only to inhibit energy-utilizing pathways, but also to stimulate the use of alternative fuels to provide energy. Thus, phosphorylation of ACCP, a resultant decrease in malonylCoA and disinhibition of CPT1, and stimulation of fatty acid oxidation, is another important function of AMPK that is most prominent, and well-documented, in heart and skeletal muscle [49] . Heart and skeletal muscle contain an isoform of C P T l that is more sensitive to inhibition by malonyl-CoA than the liver enzyme [2] . Therefore, rates of fatty acid oxidation have been shown to closely and inversely correlate with malonylCoA levels in rat cardiomyocytes [SO] , perfused working rat heart [51] and rat hindlimb [52] under a variety of conditions. The 34-fold higher rates of fatty acid oxidation in reperfused rat hearts following ischaemia are due to a dramatic decrease in malonyl-CoA concentration, caused by the phosphorylation and inactivation of ACCP in response to activation of AMPK [53] . In rat skeletal muscle, treadmill exercise [52] or electrical stimulation [54] caused activation of AMPK and subsequent phosphorylation and inactivation of ACCP leading to decreased malonyl-CoA levels. The changes in kinetic parameters of ACCP in these situations were very comparable with those seen in response to ACCP phosphorylation by AMPK in vitro [36, 52, 54] . These effects were mimicked by the incubation of isolated rat soleus muscles with the AMPK activator, AICAR. AICAR decreased ACCP activity by 50% and 
Conclusions
The two isoforms ACCa and ACCP appear to have distinct roles in the regulation of fatty acid synthesis and fatty acid oxidation, respectively. They are regulated by similar short-term mechanisms of allosteric activation by citrate and inhibition by fatty acyl-CoA, and reversible phosphorylation and inactivation. AMPK is the important physiological ACC kinase for both isoforms and yet a role for PKA cannot be ruled out, in terms of both the CAMP-mediated inactivation of ACCa and the fact that ACCP is such a good PKA substrate at sites presumed to be in the unique N-terminus. 
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